MX2021001335A - Inhibidores de ckd8/19. - Google Patents

Inhibidores de ckd8/19.

Info

Publication number
MX2021001335A
MX2021001335A MX2021001335A MX2021001335A MX2021001335A MX 2021001335 A MX2021001335 A MX 2021001335A MX 2021001335 A MX2021001335 A MX 2021001335A MX 2021001335 A MX2021001335 A MX 2021001335A MX 2021001335 A MX2021001335 A MX 2021001335A
Authority
MX
Mexico
Prior art keywords
cdk8
inhibitors
compounds
disorders
inhibitor
Prior art date
Application number
MX2021001335A
Other languages
English (en)
Spanish (es)
Inventor
Dmitry Valentinovich Morozov
Pavel Andreevich Iakovlev
Aleksei Leonidovich Mindich
Andrei Ivanovich Alafinov
Anton Aleksandrovich Evdokimov
Mariia Andreevna Kasatkina
Elena Aleksandrovna Maksimenko
Mariia Sergeevna Mishina
Anna Jur'evna Chestnova
Aleksei Sergeevich Gavrilov
Liliana Vyacheslavovna Lenshmidt
Sergei Aleksandrovich Silonov
Evgenii Jur''evich Smirnov
Original Assignee
Biocad Joint Stock Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocad Joint Stock Co filed Critical Biocad Joint Stock Co
Publication of MX2021001335A publication Critical patent/MX2021001335A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MX2021001335A 2018-08-03 2019-07-31 Inhibidores de ckd8/19. MX2021001335A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU2018128415A RU2761824C2 (ru) 2018-08-03 2018-08-03 Ингибиторы CDK8/19
PCT/RU2019/050123 WO2020027704A1 (ru) 2018-08-03 2019-07-31 Ингибиторы cdk8/19

Publications (1)

Publication Number Publication Date
MX2021001335A true MX2021001335A (es) 2021-04-12

Family

ID=69231230

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021001335A MX2021001335A (es) 2018-08-03 2019-07-31 Inhibidores de ckd8/19.

Country Status (19)

Country Link
US (1) US11840531B2 (cg-RX-API-DMAC7.html)
EP (1) EP3831829A4 (cg-RX-API-DMAC7.html)
JP (1) JP7365396B2 (cg-RX-API-DMAC7.html)
KR (1) KR102926889B1 (cg-RX-API-DMAC7.html)
CN (1) CN113166140B (cg-RX-API-DMAC7.html)
AR (1) AR115898A1 (cg-RX-API-DMAC7.html)
AU (1) AU2019313199B2 (cg-RX-API-DMAC7.html)
BR (1) BR112021001939A2 (cg-RX-API-DMAC7.html)
CA (1) CA3108298A1 (cg-RX-API-DMAC7.html)
CL (1) CL2021000282A1 (cg-RX-API-DMAC7.html)
CO (1) CO2021001174A2 (cg-RX-API-DMAC7.html)
EA (1) EA202190452A1 (cg-RX-API-DMAC7.html)
MA (1) MA52375B2 (cg-RX-API-DMAC7.html)
MX (1) MX2021001335A (cg-RX-API-DMAC7.html)
PE (1) PE20210416A1 (cg-RX-API-DMAC7.html)
PH (1) PH12021550258A1 (cg-RX-API-DMAC7.html)
RU (1) RU2761824C2 (cg-RX-API-DMAC7.html)
TW (1) TWI839374B (cg-RX-API-DMAC7.html)
WO (1) WO2020027704A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4178955A1 (en) 2020-07-11 2023-05-17 Pfizer Inc. Antiviral heteroaryl ketone derivatives
US11351149B2 (en) 2020-09-03 2022-06-07 Pfizer Inc. Nitrile-containing antiviral compounds
CA3251059A1 (en) 2022-05-02 2023-11-09 The Board Of Trustees Of The Leland Stanford Junior University Compositions, systems and methods for modulating a target gene
WO2024109660A1 (zh) * 2022-11-21 2024-05-30 上海齐鲁制药研究中心有限公司 Cdk抑制剂

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200808739A (en) 2006-04-06 2008-02-16 Novartis Vaccines & Diagnostic Quinazolines for PDK1 inhibition
EP2229375A1 (en) 2007-12-06 2010-09-22 Schering Corporation Gamma secretase modulators
EP2630122B1 (en) * 2010-10-18 2016-11-30 RaQualia Pharma Inc Arylamide derivatives as ttx-s blockers
TWI529171B (zh) * 2013-07-29 2016-04-11 赫孚孟拉羅股份公司 1,7-萘啶衍生物
JP2017522324A (ja) 2014-07-17 2017-08-10 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung 新規ナフチリジン及びイソキノリンならびにcdk8/19阻害剤としてのその使用
EP3383875B1 (en) * 2015-11-30 2022-02-09 Council Of Scientific & Industrial Research 3-pyrimidinyl pyrrolo [2,3-b] pyridine as anticancer agents and the process for the preparation thereof
EP3464267B1 (en) * 2016-05-23 2020-09-23 Boehringer Ingelheim International GmbH New phenylpyrazolylacetamide compounds and derivatives as cdk8/cdk19 inhibitors

Also Published As

Publication number Publication date
KR102926889B1 (ko) 2026-02-19
CN113166140A (zh) 2021-07-23
AR115898A1 (es) 2021-03-10
MA52375B2 (fr) 2023-02-28
US11840531B2 (en) 2023-12-12
CL2021000282A1 (es) 2021-08-13
PH12021550258A1 (en) 2021-10-11
JP2021533143A (ja) 2021-12-02
RU2018128415A3 (cg-RX-API-DMAC7.html) 2021-03-30
CA3108298A1 (en) 2020-02-06
AU2019313199A1 (en) 2021-03-11
BR112021001939A2 (pt) 2021-04-27
WO2020027704A1 (ru) 2020-02-06
CO2021001174A2 (es) 2021-02-26
KR20210040416A (ko) 2021-04-13
CN113166140B (zh) 2024-06-14
RU2761824C2 (ru) 2021-12-13
EP3831829A1 (en) 2021-06-09
AU2019313199B2 (en) 2023-07-06
US20210246138A1 (en) 2021-08-12
PE20210416A1 (es) 2021-03-04
TW202012406A (zh) 2020-04-01
EP3831829A4 (en) 2022-04-20
TWI839374B (zh) 2024-04-21
EA202190452A1 (ru) 2021-04-13
RU2018128415A (ru) 2020-02-04
JP7365396B2 (ja) 2023-10-19
MA52375A1 (fr) 2021-12-31

Similar Documents

Publication Publication Date Title
SA520412278B1 (ar) مركبات ومشتقات بيريدو بيريمينون بها استبدال ببنزيل أمينو جديدة كمثبطات جين أس أوه أس 1
MX2020001531A (es) Nuevos compuestos hetorociclicos como inhibidores de cdk8/19.
GEP20237561B (en) Protein tyrosine phosphatase inhibitors
GEP20257823B (en) Amino quinazoline derivatives as p2x3 inhibitors
PH12021550258A1 (en) Cdk8/19 inhibitors
SA520412335B1 (ar) مشتقات أوكسي فلورو ببريدين كمثبط كيناز
EA033343B1 (ru) Соединения, ингибирующие rip2-киназу, фармацевтическая композиция на их основе и их применение для лечения заболеваний, опосредуемых rip2-киназой
PH12016501338A1 (en) Indazole compounds as irak4 inhibitors
EP4371562A3 (en) 2-quinolone derived inhibitors of bcl6
TN2020000125A1 (en) Amino-fluoropiperidine derivative as kinase inhibitor
MX2020002399A (es) Inhibidores del enlace proteína-proteína de wdr5.
MX2016016516A (es) Inhibidores de fosfatidilinositol 3-cinasa.
PH12021550554A1 (en) N-substituted-dioxocyclobutenylamino-3-hydroxy-picolinamides useful as ccr6 inhibitors
MX2023009060A (es) Antagonistas de gpr84 y usos de estos.
MX2016016530A (es) Inhibidores de fosfatidilinositol 3-quinasa.
PH12021550743A1 (en) Boron containing pde4 inhibitors
MX389786B (es) Derivados de 4-metil 7-{[5-heterociclilpirazina-2-il]amino}1,2- dihidro-1,6-naftiridina-5-ona como compuestos inhibidores de cdk4/6 y el uso de los mismos para el tratamiento de cáncer.
PH12022551623A1 (en) Substituted pyrazolo-pyrimidines and uses thereof
EA201001586A1 (ru) Соединения и композиции в качестве ингибиторов itpkb
MX2019004822A (es) Derivado del pirazol 3,4-bipiridilo y metodo de preparacion del mismo y aplicacion medica del mismo.
MX2021006490A (es) Compuestos heteroaromaticos como inhibidores de vanina.
ZA202100955B (en) Thrombin inhibitors, formulations, and uses thereof
UY38133A (es) Nuevos inhibidores de cdk8/19
MX385475B (es) Derivados de piridoquinazolina eficaces como inhibidores de proteina quinasa
MX2019014438A (es) Derivados de acidos carboxilicos eficaces como inhibidores de la proteina quinasa.